Commentary/Editorials

Immunoregulatory functions of innate lymphoid cells
Sarah Q. Crome, Pamela S. Ohashi

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 121; DOI: 10.1186/s40425-018-0433-8
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
Khashayar Esfahani

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 154; DOI: 10.1186/s40425-018-0480-1
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Saman Maleki Vareki

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 157; DOI: 10.1186/s40425-018-0479-7
Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
Yaxiong Zhang, Huaqiang Zhou, Li Zhang

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 135; DOI: 10.1186/s40425-018-0427-6
Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?
Roger Sun, Francois-Xavier Danlos, Samy Ammari, Guillaume Louvel, Frédéric Dhermain, Stéphane Champiat, Olivier Lambotte, Eric Deutsch

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 96; DOI: 10.1186/s40425-017-0304-8
Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap
Frederick L. Locke, Claudio Anasetti, for the Moffitt Immunotherapy Working Group and the Immune Cell Therapy (ICE-T) Program

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 59; DOI: 10.1186/s40425-017-0265-y
It’s a long way to the top (if you want to personalize immunotherapy)
Sarah Haebe, Oliver Weigert

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 6; DOI: 10.1186/s40425-016-0207-0
FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
Stefan N. Symeonides, Stephen M. Anderton, Alan Serrels

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 17; DOI: 10.1186/s40425-017-0217-6
Potassium channels of T lymphocytes take center stage in the fight against cancer
Laura Conforti

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 2; DOI: 10.1186/s40425-016-0202-5
Immunotherapy resistance: the answers lie ahead – not in front – of us
Miles C. Andrews, Jennifer A. Wargo

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 10; DOI: 10.1186/s40425-017-0212-y

Main menu

Commentary/Editorials

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Commentary/Editorials

Pages